dronabinol has been researched along with Hepatocellular Carcinoma in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Baghaei, K; Farrokhi, N; Moghadam, VE; Salami, SA; Tajik, T | 1 |
| Díaz-Laviada, I; Guzmán, M; Olea-Herrero, N; Salazar, M; Vara, D; Velasco, G | 1 |
2 other study(ies) available for dronabinol and Hepatocellular Carcinoma
| Article | Year |
|---|---|
Extracellular vesicles of cannabis with high CBD content induce anticancer signaling in human hepatocellular carcinoma.
Topics: Analgesics; Cannabidiol; Cannabinoid Receptor Agonists; Cannabis; Carcinoma, Hepatocellular; Dronabinol; Extracellular Vesicles; Humans; Liver Neoplasms | 2022 |
Anti-tumoral action of cannabinoids on hepatocellular carcinoma: role of AMPK-dependent activation of autophagy.
Topics: AMP-Activated Protein Kinase Kinases; Animals; Antineoplastic Agents; Autophagy; Carcinoma, Hepatocellular; Cell Cycle Proteins; Cell Line, Tumor; Dronabinol; Humans; Indoles; Liver Neoplasms; Mechanistic Target of Rapamycin Complex 1; Mice; Mice, Nude; Multiprotein Complexes; Protein Kinases; Protein Serine-Threonine Kinases; Proteins; Proto-Oncogene Proteins c-akt; Receptor, Cannabinoid, CB2; Repressor Proteins; TOR Serine-Threonine Kinases; Transplantation, Heterologous | 2011 |